E80.1
Porphyria cutanea tarda
Clinical Classification Guidelines
Medical Intelligence & Overview
Porphyria cutanea tarda is a chronic skin condition characterized by fragile skin that is easily damaged when exposed to sunlight or other sources of ultraviolet light. It is the most common form of porphyria, a group of disorders caused by abnormalities in the body's ability to produce heme, a component of hemoglobin. This condition often presents with blistering and skin deterioration predominantly on sun-exposed areas.
Causes & Symptoms
Clinical Causes: Genetic factors: inherited predisposition can contribute to the disorder. Liver diseases: such as hepatitis C, cirrhosis, or alcohol-related liver damage, which impair the body's ability to process porphyrins. Iron overload: excess iron in the body can exacerbate the condition. Environmental factors: excessive sun exposure or ultraviolet light can trigger symptoms. Hormonal influences: use of estrogens or other hormones may increase risk. Certain medications: drugs that increase photosensitivity may contribute.
Key Symptoms: Blistering skin lesions on the hands, forearms, face, and neck after sun exposure. Fragile skin that tears easily or develops scars and hyperpigmentation. Because of photosensitivity, skin reactions tend to occur in sun-exposed areas. Hypertrichosis, characterized by excessive hair growth on the face or other affected areas (less common). Elevated skin fragility and delayed healing of wounds. Urticaria or itching in affected regions.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory testing. Tests may include measuring porphyrin levels in blood, urine, and stool. Skin biopsies under microscopy can show characteristic changes. An in-depth family history and assessment of liver function might also be part of the process.
Treatment Protocols: Treatment strategies focus on reducing symptoms and preventing flare-ups. These may include phlebotomy to decrease iron levels, administration of low-dose chloroquine or hydroxychloroquine to help remove porphyrins, and strict sun protection measures. Lifestyle modifications, such as avoiding alcohol and certain medications, are also recommended. Management of underlying liver disease is crucial for long-term control.
Clinical Advice & FAQs
Billing Guidance
Is E80.1 a billable ICD-10 code?
Yes, E80.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E80.1?
Clinical documentation must specify the nature of Porphyria cutanea tarda and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
